Trial intelligence / Profile preview

Preoperative Amiodarone for AF Prevention

NCT00300495Phase 3Terminated

Sponsor
Beth Israel Deaconess Medical Center
Start
Feb 2006
Primary completion
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of amiodarone in Atrial fibrillation (AFib), sponsored by Beth Israel Deaconess Medical Center. Started Feb 2006; status: terminated.

02

Drugs

amiodarone
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT00300495.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00300495.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call